C 23 H 30 FN5O 6 , monoclinic, P21/n (no. 14), a = 9.5772 (3) 
T = 150 K.
CCDC no.: 1447616
The crystal structure is shown in the gure. Tables 1-3 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. . . Table 3 : Atomic displacement parameters (Å 2 ).
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Source of material
The chemical reagents and solvents used in this study are commercially available. 
Experimental details
All hydrogen atoms were placed geometrically on calculated positions using a riding model with the help of the SHELXL program (AFIX 137 option for methyl groups, AFIX 43 option for aromatic H atoms, AFIX 13 for tertiary and AFIX 23 for secondary H atoms) [12] . The hydrogen atoms of two methyl groups (bonded to C2 and C12) are disordered.
Discussion
1,3-Dimethylbarbituric acid skeleton represents the key pharmacophore of several pharmaceutically agents. Thus, several substituted 1,3-dimethylbarbituric acid were reported to exhibit marked chemotherapeutic activities such as antioxidant, anti-in ammatory, HIV-1 and HIV-2 protease inhibitors, anticancer, anticonvulsant and sedative-hypnotic [2] [3] [4] [5] . In continues of our research program we report the crystal structure of a target molecule in this class of compounds. This contribution is part of our continuing interest in pyrimidinbased compounds [6] [7] [8] [9] [10] . The title compound comprise of a pyrimidine dione anion and a diethylammonium cation.
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